Brown, Fred, 1925-2004
Brown, Fred
Brown, Fred, 1925-
Fred Brown British virologist (1925-2004)
VIAF ID: 71452175 ( Personal )
Permalink: http://viaf.org/viaf/71452175
Preferred Forms
- 200 _ | ‡a Brown ‡b Fred ‡f 1925-2004
-
-
- 100 1 _ ‡a Brown, Fred
- 100 1 _ ‡a Brown, Fred ‡d 1925-2004
- 100 1 _ ‡a Brown, Fred ‡d 1925-2004
-
- 100 1 _ ‡a Brown, Fred, ‡d 1925-2004
-
-
- 100 1 _ ‡a Brown, Fred, ‡d 1925-2004
-
-
- 100 0 _ ‡a Fred Brown ‡c British virologist (1925-2004)
4xx's: Alternate Name Forms (15)
Works
Title | Sources |
---|---|
Advances in transfusion safety-2001 Paul-Ehrlich-Institute, Langen, Germany, June 7 and 8, 2001 | |
Advances in transfusion safety San Francisco, Ca, USA, March 18-20, 1999 proceedings of a symposium | |
Advancing science and elimination of the use of laboratory animals for development and control of vaccines and hormones Jaarbeurs Congress Centre, Utrecht, The Netherlands, November 12 - 14, 2001 ; proceedings of a symposium ; 54 tables | |
Alternatives to animals in the development and control of biological products for human and veterinary use : London Zoo, London, U.K. September 24-26, 1998 | |
celebration of 50 years of progress in biological standardization and control at WHO proceedings of a symposium, WHO Headquaters, Geneva, 25 - 27 October 1998 ; 26 tables | |
Comparability of biotechnology products | |
design and analysis of potency assays for biotechnology products National institute for biological standards and control, London, UK., October 5-6, 2000 | |
Development and clinical progress of DNA vaccines Paul-Ehrlicht-Institut, Langen, Germany, October 6-8, 1999 proceedings of a symposium | |
Development of specifications for biotechnology pharmaceutical products proceedings of a Symposium, Hyatt Regency, San Francisco, USA, May 2-3, 1996 | |
Development of therapeutic cancer vaccines : proceedings of a conference, Los Angeles, California, April 27-29, 2004 | |
Erkältungskrankheit ein Lehrbuch für die Praxis ; 24 Tabellen | |
Genetic stability and recombinant product consistency Annecy, France, July 8-9, 1993 | |
Immune recognition of protein antigens : proceedings of a Royal Society discussion meeting held on 6 and 7 July 1988 | |
Immunogenicity of therapeutic biological products : National Institutes of Health, Bethesda, MD, USA, Oct. 31st - Nov. 2nd, 2001 | |
Inactivated influenza vaccines prepared in cell culture proceedings of a meeting, National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 26 - 27, 1997 ; 44 tables | |
International Symposium on the first steps towards an international harmonization of veterinary biologicals: 1993 and free circulation of vaccines within the E.E.C. | |
Laboratory correlates of immunity to influenza--A reassessment : University of Bergen, Bergen, Norway, 2-3 May, 2002, proceedings of a scientific workshop | |
The making of a modern Quaker : Roger Cowan Wilson 1906-1991 | |
Modulation of the immune response to vaccine antigens University of Bergen, Norway, June 18 - 21, 1996 ; proceedings of a symposium ; 49 tables | |
Molecular and chemical basis of resistance to parasitic, bacterial, and viral diseases | |
New approaches to stabilisation of vaccines potency WHO headquarters, Geneva, may 29-31, 1995 | |
Orphan vaccines : bridging the gap : Palm Cove, Queensland, Australia, 25th-29th August 2001 | |
Pertussis vaccine trials : Istituto superiore di Sanità, Rome, Italy, october 30-november 1, 1995 : proceedings of a symposium | |
Physico-chemical procedures for the characterization of vaccines proceedings of a symposium, les Pensières, Veyrier-du-Lac, France, December 1-3, 1999 | |
Preclinical and clinical development of new vaccines : Institut Pasteur, Paris, France, 27-28 May 1997 | |
Process validation for manufacturing of biologics and biotechnology products Berlin Hilton Hotel, Berlin, Germany, 6-7 September, 2001 | |
Progress in fish vaccinology : The Grieg Music Hall conference centre, Bergen, Norway, April 9-11, 2003 : proceedings of the 3rd international symposium on progress in fish vaccinology | |
Progress in polio eradication vaccine strategies for the end game proceedings of a symposium, Institut Pasteur, Paris, June 28-30, 2000 | |
Recombinant vectors in vaccine development proceedings of a symposium ; Albany NY, USA, May 23 - 26, 1993 ; 32 tables | |
Safety of biological products prepared from mammalian cell culture : conference Centre of the Marcel-Mérieux Foundation, Les Pensières, Veyrier-du-Lac, Annecy, France, September 29 - October 1, 1996 | |
Simian virus 40 (SV40) a possible human polyomavirus ; Natcher Auditorium, NIH, Bethesda, Maryland, USA, January 27 and 28, 1997 ; proceedings of a workshop ; 39 tables | |
Standardization of the immunopharmacology of natural and synthetic immunomodulators | |
Test bank to accompany General statistics | |
Vaccine design | |
Vaccines 85, 1985: | |
Vaccines 86 : new approaches to immunization : developing vaccines against parasitic, bacterial, and viral diseases | |
Vaccines 92 : modern approaches to new vaccines including prevention of AIDS : [9th annual meeting on modern approaches to vaccines, September 19-23, 1991] | |
Vaccines '97 : Molecular approaches to the control of infectious diseases | |
Vaccines for OIE list A and emerging animal diseases : Scheman Conference Center, Ames, Iowa, USA, September 16-18, 2002 | |
Viral safety and evaluation of viral clearance from biopharmaceutical products proceedings of a symposium, Natcher Conference Center, Bethesda, Maryland, USA, June 14 - 16, 1995 ; 73 tables | |
Virological aspects of the safety of biological products : International symposium : Papers | |
Virological safety aspects of plasma derivatives Cannes, France, November 3-6, 1992 | |
Virology : directory & dictionary of animal, bacterial and plant viruses |